Case number 1:22-cv-01648
Mallinckrodt Pharmaceuticals Ireland Limited et al v. Airgas Therapeutics LLC et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jul 3, 2024 | 268 | REDACTED VERSION of 256 Letter, by Airgas Therapeutics LLC, Airgas USA LLC. (Attachments: # 1 Exhibits 1-3)(Haney, Megan) Modified on 7/3/2024 (nms). (Entered: 07/03/2024) (0) |
| Jul 3, 2024 | 269 | NOTICE OF SERVICE of (1) Airgas Therapeutics and Airgas USA's Third Set of Interrogatories (Nos. 9-21) and (2) Airgas Therapeutics and Airgas USA's Fourth Set of Requests for Production (Nos. 124-131) filed by Airgas Therapeutics LLC, Airgas USA LLC.(Haney, Megan) (Entered: 07/03/2024) (2) |
| Jul 3, 2024 | 270 | DECLARATION of Lars Taavola in support of 268 Redacted Document, by INO Therapeutics LLC, Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited, Mallinckrodt plc. (Metzler, Sara) Modified on 7/3/2024 (nms). (Entered: 07/03/2024) (3) |
| Jul 3, 2024 | 271 | NOTICE OF SERVICE of (1) Plaintiffs' Supplemental Responses and Objections to Defendants' First Set of Interrogatories (Nos. 1-5); (2) Plaintiffs' Seventh Set of Requests for the Production of Documents and Things (Nos. 134-142); (3) Plaintiffs' Third Set of Requests for Admission to Defendants (Nos. 11-49) and (4) Plaintiffs' Amended Rule 26(a)(1) Disclosures filed by INO Therapeutics LLC, Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited, Mallinckrodt plc.(Metzler, Sara) (Entered: 07/03/2024) (2) |
| Jul 2, 2024 | 267 | MEMORANDUM ORDER: This case has a Markman hearing scheduled for July 12. The parties should meet and confer and by the COB July 10th advise whether they accept any of the above decisions or proposals. Further, the Markman hearing is rescheduled to 10 a.m. on July 12th and is now allotted one hour, to be split equally between the sides (see Memorandum Order for further details regarding observations and proposed determinations). Signed by Judge Richard G. Andrews on 7/2/2024. (nms) (Entered: 07/02/2024) (2) |
| Jul 1, 2024 | 266 | NOTICE OF SERVICE of (1) Notice of Deposition of Patrick Blake; (2) Notice of Deposition of Jeff Milsap; and (3) Notice of Deposition of Tricia Baisley filed by Airgas Therapeutics LLC, Airgas USA LLC.(Haney, Megan) (Entered: 07/01/2024) (2) |
| Jun 28, 2024 | 264 | STIPULATION and Proposed Order for Extension of Time - filed by Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited. (Metzler, Sara) Modified on 7/1/2024 (nms). (Entered: 06/28/2024) (1) |
| Jun 28, 2024 | 265 | NOTICE OF SERVICE of Mallinckrodt's Responses and Objections to Airgas's Notice of Deposition Pursuant to Fed. R. Civ. P. 30(b)(6) filed by INO Therapeutics LLC, Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited, Mallinckrodt plc.(Metzler, Sara) (Entered: 06/28/2024) (2) |
| Jun 27, 2024 | 263 | NOTICE OF SERVICE of (1) Mallinckrodt's Amended Rule 26(a)(1) Initial Disclosures and (2) Mallinckrodt's Amended Initial Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery filed by INO Therapeutics LLC, Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited, Mallinckrodt plc.(Metzler, Sara) (Entered: 06/27/2024) (2) |
| Jun 25, 2024 | 261 | STIPULATION and Proposed Order for Extension of Time to submit the redacted version of D.I. 256 to June 28, 2024 - filed by Airgas Therapeutics LLC, Airgas USA LLC. (Haney, Megan) Modified on 6/25/2024 (nms). (Entered: 06/25/2024) (1) |
| Jun 25, 2024 | 262 | NOTICE OF SERVICE of Seventh Set of Interrogatories (No. 23) filed by INO Therapeutics LLC, Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited, Mallinckrodt plc.(Metzler, Sara) (Entered: 06/25/2024) (2) |
| Jun 21, 2024 | 259 | ORAL ORDER: For the reasons detailed during the teleconference on June 21, 2024, Plaintiffs' motion to compel (D.I. 250) is GRANTED-IN-PART and DENIED-IN-PART. In light of Plaintiffs' non-opposition (D.I. 257), Defendants' motion (D.I. 249) is DENIED as moot. The transcript of the June 21, 2024 hearing contains the Court's rationale and further details regarding the Court's ruling. Ordered by Judge Laura D. Hatcher on 6/21/24. (kjk) (Entered: 06/21/2024) (0) |
| Jun 21, 2024 | 260 | REDACTED VERSION of 250 Letter by INO Therapeutics LLC, Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited, Mallinckrodt plc. (Attachments: # 1 Exhibit 1-16)(Metzler, Sara) (Entered: 06/21/2024) (0) |
| Jun 20, 2024 | 258 | Letter to The Honorable Laura D. Hatcher from John C. Phillips, Jr. regarding Duncan Bathe dispute. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3)(Phillips, John) (Entered: 06/20/2024) (0) |
| Jun 18, 2024 | 252 | ORAL ORDER: The proposed redactions (D.I. 243 ) as supported by the declaration at D.I. 244 are ACCEPTED. Ordered by Judge Richard G. Andrews on 6/18/2024. (nms) (Entered: 06/18/2024) (0) |
| Jun 18, 2024 | 253 | APPENDIX, Volume I to 247 Joint Claim Construction Brief, by Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited, Mallinckrodt plc. (Attachments: # 1 Exhibits 1-21)(Metzler, Sara) Modified on 6/18/2024 (nms). (Entered: 06/18/2024) (0) |
| Jun 18, 2024 | 254 | APPENDIX, Volume II to 247 Joint Claim Construction Brief, by Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited, Mallinckrodt plc. (Attachments: # 1 Exhibits 22-33, # 2 Exhibits 34-38)(Metzler, Sara) Modified on 6/18/2024 (nms). (Entered: 06/18/2024) (0) |
| Jun 18, 2024 | 255 | Letter to The Honorable Laura D. Hatcher, from Frederick L. Cottrell, III, regarding Mallinckrodt dispute regarding Mr. Bathe. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Cottrell, Frederick) Modified on 6/18/2024 (nms). (Entered: 06/18/2024) (0) |
| Jun 18, 2024 | 256 | [SEALED] Letter to The Honorable Laura D. Hatcher, from John C. Phillips, Jr., regarding opposition to Plaintiffs' motion to compel. (Attachments: # 1 Exhibits 1-3)(Phillips, John) Modified on 6/18/2024 (nms). (Entered: 06/18/2024) (0) |
| Jun 18, 2024 | 257 | [SEALED] Letter to The Honorable Laura D. Hatcher, from Frederick L. Cottrell, III, regarding opposition to Defendants' letter regarding discovery dispute (D.I. 249 ). (Attachments: # 1 Exhibits A-D)(Cottrell, Frederick) Modified on 6/20/2024 (nms). (Entered: 06/18/2024) (0) |
| Jun 17, 2024 | 251 | NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Defendants' Second Set of Interrogatories (Nos. 6-8) filed by INO Therapeutics LLC, Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited, Mallinckrodt plc.(Metzler, Sara) (Entered: 06/17/2024) (2) |
| Jun 14, 2024 | 243 | REDACTED VERSION of 230 Letter by INO Therapeutics LLC, Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited, Mallinckrodt plc. (Attachments: # 1 Exhibit A-J)(Metzler, Sara) (Entered: 06/14/2024) (0) |
| Jun 14, 2024 | 244 | DECLARATION Lars Taavola in further support of 243 Redacted Document, by INO Therapeutics LLC, Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited, Mallinckrodt plc. (Metzler, Sara) Modified on 6/17/2024 (nms). (Entered: 06/14/2024) (3) |
| Jun 14, 2024 | 245 | MOTION for Pro Hac Vice Appearance of Attorney Maxwell C. Ruocco - filed by Airgas Therapeutics LLC, Airgas USA LLC. (Haney, Megan) (Entered: 06/14/2024) (3) |
| Jun 14, 2024 | 246 | Pro Hac Vice Fee - Credit Card Payment received for Maxwell C. Ruocco. ( re 245 MOTION for Pro Hac Vice Appearance of Attorney Maxwell C. Ruocco )( Payment of $ 50, receipt number ADEDC-4430512).(Haney, Megan) (Entered: 06/14/2024) (0) |
| Jun 14, 2024 | 247 | JOINT Claim Construction Brief, filed by INO Therapeutics LLC, Mallinckrodt plc, Mallinckrodt Pharmaceuticals Ireland Limited, Mallinckrodt Hospital Products IP Unlimited Company. (Metzler, Sara) Modified on 6/17/2024 (nms). (Entered: 06/14/2024) (30) |
| Jun 14, 2024 | 249 | Letter to The Honorable Laura D. Hatcher, from John C. Phillips, Jr., regarding discovery dispute. (Attachments: # 1 Proposed Order, # 2 Exhibits 1-3)(Phillips, John) Modified on 6/17/2024 (nms). (Entered: 06/14/2024) (0) |
| Jun 14, 2024 | 250 | [SEALED] Letter to The Honorable Laura D. Hatcher, from Sara M. Metzler, regarding motion to compel production of documents. (Attachments: # 1 Exhibits 1-16)(Metzler, Sara) Modified on 6/17/2024 (nms). (Entered: 06/14/2024) (0) |
| Jun 13, 2024 | 240 | ORAL ORDER: The Court has reviewed the Joint Motion for Teleconference to Resolve Discovery Disputes (D.I. 236). A teleconference is scheduled for Friday, June 21, 2024 at 1:00 PM Eastern before Judge Laura D. Hatcher. By no later than Friday, June 14, 2024, any party seeking relief shall file with the Court a letter not to exceed three pages in no less than 12-point font outlining the issues in dispute and that party's position on those issues. By no later than Tuesday, June 18, 2024, any party opposing the application for relief may file a letter not to exceed three pages in no less than 12-point font outlining its opposition. Counsel is reminded to promptly provide courtesy copies. Counsel shall send dial-in information directly to the Court no later than 24 hours prior to the hearing using the following e-mail address: keith_kincaid@ded.uscourts.gov. The Court may choose to resolve the dispute prior to the telephone conference and will, in that event, cancel the conference.Ordered by Judge Laura D. Hatcher on 6/13/24. (kjk) (Entered: 06/13/2024) (0) |
| Jun 13, 2024 | 241 | ORAL ORDER. By no later than Tuesday, June 18, 2024, Plaintiffs are directed to file a letter not to exceed three pages in no less than 12-point font outlining the basis for their motion to preclude Defendants from using Mr. Bathe in the disclosed capacity. By no later than Thursday, June 20, 2024, Defendants may file a letter not to exceed three pages in no less than 12-point font in response. Counsel are reminded to promptly provide courtesy copies. Upon review of the letters, the Court will determine whether a hearing is necessary. Ordered by Judge Laura D. Hatcher on 6/13/24. (kjk) (Entered: 06/13/2024) (0) |
| Jun 13, 2024 | 242 | Responses and Objection to Plaintiffs' Requests for Production and Notice of Deposition (D.I. 221 ), by Getinge USA Sales, LLC. (Attachments: # 2 Certificate of Service)(Shields, Colleen) Modified on 6/13/2024 (nms). Modified on 6/13/2024 (nms). Modified on 6/14/2024 (oam). (Entered: 06/13/2024) (0) |
| Jun 12, 2024 | 237 | NOTICE OF SERVICE of (1) Plaintiffs' Notice of Deposition of Steven Miller Pursuant to Fed. R. Civ. P. 30(b)(1); (2) Plaintiffs' Notice of Deposition of Tim Warren Pursuant to Fed. R. Civ. P. 30(b)(1); (3) Plaintiffs' Notice of Deposition of Patricia-Ann Therriault Pursuant to Fed. R. Civ. P. 30(b)(1); (4) Plaintiffs' Notice of Deposition of Troy Fowler Pursuant to Fed. R. Civ. P. 30(b)(1); (5) Plaintiffs' Notice of Deposition of Robert Thompson Pursuant to Fed. R. Civ. P. 30(b)(1); (6) Plaintiffs' Notice of Deposition of Matt Matthew Pursuant to Fed. R. Civ. P. 30(b)(1) filed by INO Therapeutics LLC, Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited, Mallinckrodt plc.(Metzler, Sara) (Entered: 06/12/2024) (2) |
| Jun 12, 2024 | 238 | NOTICE OF SERVICE of Airgas Therapeutics and Airgas USA's Objections and Responses to Plaintiffs' Sixth Set of Interrogatories (Nos. 19-22) filed by Airgas Therapeutics LLC, Airgas USA LLC.(Haney, Megan) (Entered: 06/12/2024) (2) |
| Jun 12, 2024 | 239 | NOTICE OF SERVICE of Plaintiffs' Sixth Set of Requests for the Production of Documents and Things (Nos. 113-133) and Plaintiffs' Deposition Notice for Defendants Pursuant to Fed. R. Civ. P. 30(b)(6) filed by INO Therapeutics LLC, Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited, Mallinckrodt plc.(Metzler, Sara) (Entered: 06/12/2024) (2) |
| Jun 11, 2024 | 235 | NOTICE OF SERVICE of Defendants' Sur-Reply Claim Construction Brief filed by Airgas Therapeutics LLC, Airgas USA LLC.(Haney, Megan) (Entered: 06/11/2024) (2) |
| Jun 11, 2024 | 236 | Joint Motion for Teleconference to Resolve Discovery Disputes - filed by Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited, Mallinckrodt plc. Motions referred to Laura D. Hatcher.(Metzler, Sara) Modified on 6/12/2024 (nms). (Entered: 06/11/2024) (2) |
| Jun 10, 2024 | 234 | NOTICE OF SERVICE of Defendants' 30(b)(6) Notice, Notice of Deposition of David Wessel, Notice of Deposition of James Baldassarre, Notice of Deposition of Jaron Acker, Notice of Deposition of Jeffrey Rosenthal, and Notice of Deposition of Paul Coiante filed by Airgas Therapeutics LLC, Airgas USA LLC.(Haney, Megan) (Entered: 06/10/2024) (2) |
| Jun 7, 2024 | 233 | Letter to The Honorable Laura D. Hatcher, from John C. Phillips, Jr., regarding discovery dispute. (Attachments: # 1 Exhibit A)(Phillips, John) Modified on 6/9/2024 (nms). (Entered: 06/07/2024) (0) |
| Jun 6, 2024 | 231 | NOTICE OF SERVICE of (1) Plaintiffs' Supplemental Responses and Objections to Defendants' First Set of Requests for Production of Documents and Things (Nos. 1-89); (2) Plaintiffs Supplemental Responses and Objections to Defendants Second Set of Requests for Production of Documents and Things (Nos. 90-114); and (3) Plaintiffs Supplemental Responses and Objections to Defendants Third Set of Requests for Production of Documents and Things (Nos. 115-123) filed by INO Therapeutics LLC, Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited, Mallinckrodt plc.(Metzler, Sara) (Entered: 06/06/2024) (2) |
| Jun 6, 2024 | 232 | STIPULATION and Proposed Order for Extension of Time to submit a redacted version of D.I. 230 to June 14, 2024 - filed by INO Therapeutics LLC, Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt plc. (Metzler, Sara) Modified on 6/7/2024 (nms). (Entered: 06/06/2024) (1) |
| Jun 4, 2024 | 230 | [SEALED] Letter to The Honorable Laura D. Hatcher, from Sara M. Metzler, regarding protective order dispute. (Attachments: # 1 Exhibits A-J)(Metzler, Sara) Modified on 6/4/2024 (nms). (Entered: 06/04/2024) (0) |
| May 30, 2024 | 229 | ORAL ORDER: The Court has reviewed the Joint Motion for Teleconference to Resolve Protective Order Dispute (D.I. 228). A teleconference is scheduled for Thursday, June 13, 2024 at 10:00 AM Eastern before Judge Laura D. Hatcher. By no later than Tuesday, June 4, 2024, any party seeking relief shall file with the Court a letter not to exceed three pages in no less than 12-point font outlining the issues in dispute and that party's position on those issues. By no later than Friday, June 7, 2024, any party opposing the application for relief may file a letter not to exceed three pages in no less than 12-point font outlining its opposition. Counsel is reminded to promptly provide courtesy copies. Counsel shall send dial-in information directly to the Court no later than 24 hours prior to the hearing using the following e-mail address: keith_kincaid@ded.uscourts.gov. The Court may choose to resolve the dispute prior to the telephone conference and will, in that event, cancel the conference.Ordered by Judge Laura D. Hatcher on 5/30/24. (kjk) (Entered: 05/30/2024) (0) |
| May 29, 2024 | 228 | Joint Motion for Teleconference to Resolve Protective Order Dispute - filed by INO Therapeutics LLC, Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited, Mallinckrodt plc. Motions referred to Laura D. Hatcher.(Metzler, Sara) Modified on 5/29/2024 (nms). (Entered: 05/29/2024) (2) |
| May 17, 2024 | 227 | NOTICE OF SERVICE of Airgas Therapeutics and Airgas USA's Second Set of Interrogatories (Nos. 6-8) filed by Airgas Therapeutics LLC, Airgas USA LLC.(Haney, Megan) (Entered: 05/17/2024) (2) |
| May 13, 2024 | 226 | NOTICE OF SERVICE of Plaintiffs' Sixth Set of Interrogatories (Nos. 19-22) filed by INO Therapeutics LLC, Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited, Mallinckrodt plc.(Metzler, Sara) (Entered: 05/13/2024) (2) |
| May 8, 2024 | 225 | ORAL ORDER: The revised redactions filed at D.I. 220 are APPROVED. Ordered by Judge Richard G. Andrews on 5/8/2024. (nms) (Entered: 05/08/2024) (0) |
| May 7, 2024 | 221 | NOTICE of Subpoena to Getinge USA Sales, LLC by INO Therapeutics LLC, Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited, Mallinckrodt plc (Attachments: # 1 Exhibit 1)(Metzler, Sara) (Entered: 05/07/2024) (0) |
| May 7, 2024 | 222 | NOTICE of Subpoena to Vizient, Inc. by INO Therapeutics LLC, Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited, Mallinckrodt plc (Attachments: # 1 Exhibit 1)(Metzler, Sara) (Entered: 05/07/2024) (0) |
| May 7, 2024 | 223 | NOTICE of Subpoena to Premier, Inc. by INO Therapeutics LLC, Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited, Mallinckrodt plc (Attachments: # 1 Exhibit 1)(Metzler, Sara) (Entered: 05/07/2024) (0) |
| May 7, 2024 | 224 | NOTICE of Subpoena to HealthTrust Performance Group by INO Therapeutics LLC, Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited, Mallinckrodt plc (Attachments: # 1 Exhibit 1)(Metzler, Sara) (Entered: 05/07/2024) (0) |
| May 6, 2024 | 220 | REDACTED VERSION of 196 Letter by Airgas Therapeutics LLC, Airgas USA LLC. (Attachments: # 1 Exhibits A-C)(Phillips, John) (Entered: 05/06/2024) (0) |
| May 3, 2024 | 213 | JOINT Claim Construction Chart, Volume 1 of 7, by INO Therapeutics LLC, Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited, Mallinckrodt plc. (Attachments: # 1 Exhibit A, # 2 Exhibits 1-4)(Metzler, Sara) Modified on 5/3/2024 (nms). (Entered: 05/03/2024) (0) |
| May 3, 2024 | 214 | Joint Claim Construction Chart, Volume 2 of 7, by INO Therapeutics LLC, Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited, Mallinckrodt plc. (Attachments: # 1 Exhibits 5-6, # 2 Exhibit 7 part 1)(Metzler, Sara) Modified on 5/3/2024 (nms). (Entered: 05/03/2024) (0) |
| May 3, 2024 | 215 | Joint Claim Construction Chart, Volume 3 of 7, by INO Therapeutics LLC, Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited, Mallinckrodt plc. (Attachments: # 1 Exhibit 7 part 2, # 2 Exhibit 8 part 1)(Metzler, Sara) Modified on 5/3/2024 (nms). (Entered: 05/03/2024) (0) |
| May 3, 2024 | 216 | Joint Claim Construction Chart, Volume 4 of 7, by INO Therapeutics LLC, Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited, Mallinckrodt plc. (Attachments: # 1 Exhibit 8 part 2, # 2 Exhibits 9-13)(Metzler, Sara) Modified on 5/3/2024 (nms). (Entered: 05/03/2024) (0) |
| May 3, 2024 | 217 | Joint Claim Construction Chart, Volume 5 of 7, by INO Therapeutics LLC, Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited, Mallinckrodt plc. (Attachments: # 1 Exhibits 14-17, # 2 Exhibit 18 part 1)(Metzler, Sara) Modified on 5/3/2024 (nms). (Entered: 05/03/2024) (0) |
| May 3, 2024 | 218 | Joint Claim Construction Chart, Volume 6 of 7, by INO Therapeutics LLC, Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited, Mallinckrodt plc. (Attachments: # 1 Exhibit 18 part 2, # 2 Exhibits 19-21)(Metzler, Sara) Modified on 5/3/2024 (nms). (Entered: 05/03/2024) (0) |
| May 3, 2024 | 219 | Joint Claim Construction Chart, Volume 7 of 7, by INO Therapeutics LLC, Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited, Mallinckrodt plc. (Attachments: # 1 Exhibit 22)(Metzler, Sara) Modified on 5/3/2024 (nms). (Entered: 05/03/2024) (0) |
| May 2, 2024 | 212 | ORAL ORDER: At the request of the parties, and due to a recent scheduling conflict, the Markman Hearing scheduled for 6/28/2024, is CANCELED. The Markman Hearing is now rescheduled for 7/12/2024, at 9:00 AM in Courtroom 6A. Ordered by Judge Richard G. Andrews on 5/2/2024. (nms) (Entered: 05/02/2024) (0) |
| Apr 30, 2024 | 210 | REDACTED VERSION of 197 Letter by Airgas Therapeutics LLC, Airgas USA LLC. (Phillips, John) (Entered: 04/30/2024) (3) |
| Apr 30, 2024 | 211 | REDACTED VERSION of 196 Letter by Airgas Therapeutics LLC, Airgas USA LLC. (Phillips, John) (Entered: 04/30/2024) (5) |
| Apr 29, 2024 | 208 | ORAL ORDER: The claim construction schedule as outline in the letter at D.I. 207 is APPROVED. A Joint Claim Construction Brief is due to be filed by 6/14/2024, and a Markman hearing is set for 6/28/2024, at 10:00 AM in Courtroom 6A. Ordered by Judge Richard G. Andrews on 4/29/2024. (nms) (Entered: 04/29/2024) (0) |
| Apr 29, 2024 | 209 | ORAL ORDER: The amount of redactions in the letters arguing the merits of the preliminary injunction motion are clearly a lot more than are necessary. For D.I. 196 , the only permitted redaction is the name of the Mallinckrodt customer. For D.I. 197 , the only permitted redactions are the names of customers and the number of devices in the contract with a customer. Airgas is to file revised redacted versions of D.I. 196 & D.I. 197 by the COB April 30, 2024. The redactions to the exhibits that accompany D.I. 196 & D.I. 197 are excessive too, and there is nothing that can be redacted in toto, but the Court will give Airgas a week to submit revised redacted exhibits in compliance with Avandia, since there does seem to be a substantial number of redactions that can be justified. Ordered by Judge Richard G. Andrews on 4/29/2024. (nms) (Entered: 04/29/2024) (0) |
| Apr 26, 2024 | 204 | REDACTED VERSION of 196 Letter by INO Therapeutics LLC, Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited, Mallinckrodt plc. (Attachments: # 1 Exhibit A-C)(Metzler, Sara) (Entered: 04/26/2024) (0) |
| Apr 26, 2024 | 205 | REDACTED VERSION of 197 Letter by Airgas Therapeutics LLC, Airgas USA LLC. (Phillips, John) (Entered: 04/26/2024) (3) |
| Apr 26, 2024 | 206 | DECLARATION of Troy Fowler in support of 205 Redacted Document and 204 Redacted Document, by Airgas Therapeutics LLC, Airgas USA LLC. (Phillips, John) Modified on 4/26/2024 (nms). (Entered: 04/26/2024) (3) |
| Apr 26, 2024 | 207 | Joint Letter to The Honorable Richard G. Andrews, from Sara M. Metzler, regarding claim construction issues. (Metzler, Sara) Modified on 4/26/2024 (nms). (Entered: 04/26/2024) (2) |
| Apr 24, 2024 | 203 | STIPULATION and Proposed Order for Extension of Time to submit redacted versions of D.I. 196 and D.I. 197 to April 26, 2024 - filed by INO Therapeutics LLC, Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited, Mallinckrodt plc. (Metzler, Sara) Modified on 4/25/2024 (nms). (Entered: 04/24/2024) (1) |
| Apr 18, 2024 | 202 | STIPULATION and Proposed Order for Extension of Time - filed by Airgas Therapeutics LLC, Airgas USA LLC. (Haney, Megan) Modified on 4/18/2024 (nms). (Entered: 04/18/2024) (1) |
| Apr 17, 2024 | 201 | NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Defendants' First Set of Interrogatories (Nos. 1-5) filed by INO Therapeutics LLC, Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited, Mallinckrodt plc.(Metzler, Sara) (Entered: 04/17/2024) (2) |
| Apr 16, 2024 | 200 | NOTICE OF SERVICE of (1) Airgas Therapeutics and Airgas USA's Objections and Responses to Plaintiffs' Second Set of Requests for Admission to Defendant; (2) Airgas Therapeutics and Airgas USA's Objections and Responses to Plaintiffs Fifth Set of Interrogatories (Nos. 15-18) and (3) Airgas Therapeutics and Airgas USA's Objections and Responses to Plaintiffs' Fifth Set of Requests for the Production of Documents and Things (Nos. 107-112) filed by Airgas Therapeutics LLC, Airgas USA LLC.(Haney, Megan) (Entered: 04/16/2024) (2) |
| Apr 12, 2024 | 197 | [SEALED] Letter to The Honorable Richard G. Andrews, from John C. Phillips, Jr., regarding response to Plaintiffs' supplemental authority for its preliminary injunction motion. (Phillips, John) Modified on 4/12/2024 (nms). (Entered: 04/12/2024) (0) |
| Apr 12, 2024 | 198 | NOTICE OF SERVICE of Plaintiffs' Proposed Terms for Claim Construction and Proposed Claim Constructions filed by INO Therapeutics LLC, Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited, Mallinckrodt plc.(Metzler, Sara) (Entered: 04/12/2024) (2) |
| Apr 12, 2024 | 199 | NOTICE OF SERVICE of Defendant Airgas Therapeutics, LLC and Airgas USA, LLC's Preliminary Identification of Claim Term(s)/Phrase(s) for Construction and Proposed Constructions filed by Airgas Therapeutics LLC, Airgas USA LLC.(Haney, Megan) (Entered: 04/12/2024) (2) |
| Apr 11, 2024 | 196 | [SEALED] Letter to The Honorable Richard G. Andrews, from Sara M. Metzler, regarding supplemental authority regarding Motion for Preliminary Injunction (D.I. 75 ). (Attachments: # 1 Exhibits A-C)(Metzler, Sara) Modified on 4/11/2024 (nms). (Entered: 04/11/2024) (0) |
| Apr 4, 2024 | 195 | NOTICE OF SERVICE of Defendants Airgas Therapeutics, LLC and Airgas USA, LLC's Initial Invalidity Contentions for the '046 and '118 Patents filed by Airgas Therapeutics LLC, Airgas USA LLC.(Phillips, John) (Entered: 04/04/2024) (2) |
| Apr 3, 2024 | 194 | NOTICE OF SERVICE of Plaintiffs' Responses and Objections to Defendants' First Set of Requests for Inspection and Testing (No. 1) filed by INO Therapeutics LLC, Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited, Mallinckrodt plc.(Farnan, Kelly) (Entered: 04/03/2024) (2) |
| Mar 25, 2024 | 193 | NOTICE OF SERVICE of Airgas Therapeutics and Airgas USA's Objections and Responses to Plaintiff's Fourth Set of Interrogatories (Nos. 7-14) and Airgas Therapeutics and Airgas USA's Objections and Responses to Plaintiffs' Fourth Set of Requests for the Production of Documents and Things (Nos. 83-106) filed by Airgas Therapeutics LLC, Airgas USA LLC.(Haney, Megan) (Entered: 03/25/2024) (2) |
| Mar 22, 2024 | 192 | MEMORANDUM ORDER: The motion to dismiss (D.I. 37 ) is GRANTED. The Dismissal is without prejudice. Signed by Judge Richard G. Andrews on 3/22/2024. (nms) (Entered: 03/22/2024) (10) |
| Mar 18, 2024 | 191 | NOTICE OF SERVICE of Airgas Therapeutics and Airgas USA's First Set of Interrogatories (Nos. 1-5) filed by Airgas Therapeutics LLC, Airgas USA LLC.(Haney, Megan) (Entered: 03/18/2024) (2) |
| Mar 15, 2024 | 190 | NOTICE requesting Clerk to remove James S. Fullmer as co-counsel.. (Farnan, Brian) (Entered: 03/15/2024) (1) |
| Mar 14, 2024 | 189 | NOTICE OF SERVICE of (1) Plaintiffs Fifth Set of Interrogatories (Nos. 1518), (2) Plaintiffs Fifth Set of Requests for the Production of Documents and Things (Nos. 107112), and (3) Plaintiffs Second Set of Requests for Admission (NO. 10) filed by INO Therapeutics LLC, Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited, Mallinckrodt plc.(Metzler, Sara) (Entered: 03/14/2024) (2) |
| Mar 11, 2024 | 187 | NOTICE OF SERVICE of Airgas Therapeutics and Airgas USA's Supplemental Objections and Responses to Plaintiffs' Second Set of Interrogatories (Nos. 3-5) filed by Airgas Therapeutics LLC, Airgas USA LLC.(Haney, Megan) (Entered: 03/11/2024) (2) |
| Mar 11, 2024 | 188 | ANSWER to 182 Answer to Amended Complaint,, Counterclaim, by INO Therapeutics LLC, Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited, Mallinckrodt plc.(Metzler, Sara) (Entered: 03/11/2024) (29) |
| Mar 5, 2024 | 186 | NOTICE OF SERVICE of (1) Mallinckrodt PLC, Mallinckrodt Pharmaceuticals Ireland Limited, Mallinckrodt Hospital Products IP Unlimited Company, and INO Therapeutics LLC's Initial Infringement Contentions for U.S. Patent Nos. 9,917,118 and 10,773,046 and First Supplemental Infringement Contentions for U.S. Patent Nos. 8,795,741, 8,776,794, 8,776,795, AND 9,279,794 and (2) Plaintiffs' Supplemental Identification of Accused Products and Asserted Patents filed by INO Therapeutics LLC, Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited, Mallinckrodt plc.(Metzler, Sara) (Entered: 03/05/2024) (2) |
| Mar 4, 2024 | 185 | NOTICE OF SERVICE of Airgas Therapeutics and Airgas USA's First Request for Inspection and Testing to Plaintiffs filed by Airgas Therapeutics LLC, Airgas USA LLC.(Haney, Megan) (Entered: 03/04/2024) (2) |
| Feb 28, 2024 | 183 | NOTICE OF SERVICE of Airgas' Sur-Reply Claim Construction Brief filed by Airgas Therapeutics LLC, Airgas USA LLC.(Haney, Megan) (Entered: 02/28/2024) (2) |
| Feb 28, 2024 | 184 | NOTICE of Withdrawal of Counsel, Grace Tuyiringire by INO Therapeutics LLC, Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited, Mallinckrodt plc (Metzler, Sara) (Entered: 02/28/2024) (2) |
| Feb 26, 2024 | 182 | ANSWER to 173 Amended Complaint with Jury Demand, and COUNTERCLAIMS against INO Therapeutics LLC, Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited, by Airgas Therapeutics LLC, Airgas USA LLC.(Phillips, John) Modified on 2/26/2024 (nms). (Entered: 02/26/2024) (30) |
| Feb 23, 2024 | 181 | NOTICE OF SERVICE of (1) Plaintiffs' Fourth Set of Interrogatories to Defendants (Nos. 7-14) and (2) Plaintiffs' Fourth Set of Requests for the Production of Documents and Things (Nos. 83-106) to Defendants filed by INO Therapeutics LLC, Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited, Mallinckrodt plc.(Metzler, Sara) (Entered: 02/23/2024) (2) |
| Feb 14, 2024 | 176 | Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Mallinckrodt plc. (Metzler, Sara) (Entered: 02/14/2024) (1) |
| Feb 14, 2024 | 177 | Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Mallinckrodt plc for INO Therapeutics LLC filed by INO Therapeutics LLC. (Metzler, Sara) (Entered: 02/14/2024) (1) |
| Feb 14, 2024 | 178 | REDACTED VERSION of 161 Letter by INO Therapeutics LLC, Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited, Mallinckrodt plc. (Attachments: # 1 Exhibit A-G, # 2 Text of Proposed Order)(Cottrell, Frederick) (Entered: 02/14/2024) (0) |
| Feb 14, 2024 | 179 | REDACTED VERSION of 163 Letter by INO Therapeutics LLC, Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited, Mallinckrodt plc. (Cottrell, Frederick) (Entered: 02/14/2024) (6) |
| Feb 14, 2024 | 180 | REDACTED VERSION of 162 Letter, by Airgas Therapeutics LLC, Airgas USA LLC. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Proposed Order)(Phillips, John) (Entered: 02/14/2024) (0) |
| Feb 13, 2024 | 175 | SCHEDULING ORDER: Discovery due by 8/2/2024. Dispositive Motions due by 3/21/2025, Answering Briefs due by 4/18/2025, Reply Briefs due by 4/25/2025. A 5-day Jury Trial is set to start 9/8/2025, at 9:30 AM in Courtroom 6A. A Pretrial Conference is set for 8/22/2025, at 9:00 AM in Courtroom 6A (see Order for further details). Signed by Judge Richard G. Andrews on 2/13/2024. (nms) (Entered: 02/13/2024) (12) |
| Feb 12, 2024 | 173 | Amended Complaint* (1) |
| Feb 12, 2024 | 170 | SO ORDERED Granting 166 Stipulation and Proposed Order of Partial Dismissal with Prejudice regarding the '570, '996, '284, '163, '904, '209, '210, '911, '802, and '993 patents. Signed by Judge Richard G. Andrews on 2/12/2024. (nms) (Entered: 02/12/2024) (3) |
| Feb 12, 2024 | 171 | SO ORDERED Granting 167 Joint Stipulation Regarding Motion to Dismiss of Defendant Air Liquide S.A.. Signed by Judge Richard G. Andrews on 2/12/2024. (nms) (Entered: 02/12/2024) (3) |
| Feb 12, 2024 | 172 | SO ORDERED Granting 168 Stipulation and Proposed Order to Amend Complaint. Signed by Judge Richard G. Andrews on 2/12/2024. (nms) (Entered: 02/12/2024) (2) |
| Feb 12, 2024 | 174 | Official Transcript of Discovery Conference held on 2/6/24 before Judge Laura Hatcher. Court Reporter Deanna Warner, Email: deanna_warner@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 3/4/2024. Redacted Transcript Deadline set for 3/14/2024. Release of Transcript Restriction set for 5/13/2024. (Warner, Deanna) (Entered: 02/12/2024) (21) |
| Feb 9, 2024 | 166 | Notice and Stipulation and Proposed Order of Partial Dismissal with Prejudice, by Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited. (Metzler, Sara) Modified on 2/12/2024 (nms). (Entered: 02/09/2024) (3) |
| Feb 9, 2024 | 167 | Joint Stipulation Regarding Motion to Dismiss of Defendant Air Liquide S.A., by Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited. (Metzler, Sara) Modified on 2/12/2024 (nms). (Entered: 02/09/2024) (3) |
| Feb 9, 2024 | 168 | STIPULATION and Proposed Order to Amend Complaint, by Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited. (Attachments: # 1 Exhibit A, # 2 Exhibit B). Modified on 2/12/2024 (nms). (Entered: 02/09/2024) (0) |
| Feb 9, 2024 | 169 | PROPOSED Scheduling Order, by Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited. (Metzler, Sara) Modified on 2/12/2024 (nms). (Entered: 02/09/2024) (14) |
| Feb 7, 2024 | 165 | STIPULATION and Proposed Order for Extension of Time to submit redacted versions of D.I. 161, 162 and 163 to February 14, 2024 - filed by Airgas Therapeutics LLC, Airgas USA LLC. (Haney, Megan) Modified on 2/8/2024 (nms). (Entered: 02/07/2024) (1) |
| Feb 2, 2024 | 163 | [SEALED] Letter to The Honorable Laura D. Hatcher, from Frederick L. Cottrell, III, regarding response to discovery dispute letter (D.I. 162 ). (Cottrell, Frederick) Modified on 2/5/2024 (nms). (Entered: 02/02/2024) (0) |
| Feb 2, 2024 | 164 | Letter to the Honorable Laura D. Hatcher, from John C. Phillips, Jr., regarding response to discovery dispute letter (D.I. 161 ). (Attachments: # 1 Exhibit 1)(Phillips, John) Modified on 2/5/2024 (nms). (Entered: 02/02/2024) (0) |
| Jan 31, 2024 | 161 | [SEALED] Letter to The Honorable Laura D. Hatcher, from Frederick L. Cottrell, III, regarding discovery dispute. (Attachments: # 1 Exhibits A-G, # 2 Proposed Order)(Cottrell, Frederick) Modified on 1/31/2024 (nms). (Entered: 01/31/2024) (0) |
| Jan 31, 2024 | 162 | [SEALED] Letter to the Honorable Laura D. Hatcher from John C. Phillips, Jr. regarding Discovery Dispute - re 159 Oral Order,,,,, Order Setting Teleconference,,,,. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Text of Proposed Order)(Phillips, John) (Entered: 01/31/2024) (0) |
| Jan 29, 2024 | 159 | ORAL ORDER. The Court has reviewed the Joint Motion for Teleconference to Resolve Discovery Disputes (D.I. 152). A teleconference is scheduled for Tuesday, February 6, 2024 at 3:00 PM Eastern Time before Judge Laura D. Hatcher. By no later than Wednesday, January 31, 2024, any party seeking relief shall file with the Court a letter not to exceed three pages in no less than 12-point font outlining the issues in dispute and that party's position on those issues. By no later than Friday, February 2, 2024, any party opposing the application for relief may file a letter not to exceed three pages in no less than 12-point font outlining its opposition. Counsel is reminded to provide courtesy copies. Counsel shall send dial-in information directly to the Court no later than 24 hours prior to the hearing using the following e-mail address: keith_kincaid@ded.uscourts.gov. The Court may choose to resolve the disputes prior to the telephone conference and will in that event cancel the conference. Ordered by Judge Laura D. Hatcher on 1/29/24. (kjk) (Entered: 01/29/2024) (0) |
| Jan 29, 2024 | 160 | STIPULATION and [Proposed] Order for Extension of Time, by Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited. (Farnan, Kelly) Modified on 1/30/2024 (nms). (Entered: 01/29/2024) (1) |
| Jan 25, 2024 | 158 | NOTICE OF SERVICE of Defendants' Answering Claim Construction Brief filed by Airgas Therapeutics LLC, Airgas USA LLC.(Haney, Megan) (Entered: 01/25/2024) (2) |
| Jan 22, 2024 | 157 | NOTICE OF SERVICE of Airgas Therapeutics and Airgas USA's Objections and Responses to Plaintiffs' Third Set of Requests for the Production of Documents and Things (Nos. 70-82) filed by Airgas Therapeutics LLC, Airgas USA LLC.(Haney, Megan) (Entered: 01/22/2024) (2) |
| Jan 16, 2024 | 156 | SO ORDERED Granting 155 Source Code Addendum. Signed by Judge Richard G. Andrews on 1/16/2024. (nms) (Entered: 01/16/2024) (19) |
| Jan 12, 2024 | 155 | PROPOSED Source Code Addendum, by Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited. (Metzler, Sara) Modified on 1/12/2024 (nms). (Entered: 01/12/2024) (19) |
| Jan 11, 2024 | 152 | Joint Motion for Teleconference to Resolve Discovery Disputes - filed by Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited. Motions referred to Laura D. Hatcher.(Metzler, Sara) Modified on 1/12/2024 (nms). (Entered: 01/11/2024) (2) |
| Jan 11, 2024 | 153 | MOTION for Pro Hac Vice Appearance of Attorney Daniel S. Block - filed by Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited. (Metzler, Sara) (Entered: 01/11/2024) (3) |
| Jan 11, 2024 | 154 | Pro Hac Vice Fee - Credit Card Payment received for Daniel S. Block. ( re 153 MOTION for Pro Hac Vice Appearance of Attorney Daniel S. Block )( Payment of $ 50, receipt number ADEDC-4312938).(Metzler, Sara) (Entered: 01/11/2024) (0) |
| Jan 2, 2024 | 151 | NOTICE OF SERVICE of Plaintiffs' Responses and Objections to Defendants' Third Set of Requests for Production of Documents and Things (Nos. 115123) filed by Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited.(Metzler, Sara) (Entered: 01/02/2024) (2) |
| Dec 22, 2023 | 149 | NOTICE OF SERVICE of Defendants Airgas Therapeutics, LLC and Airgas USA, LLC's Initial Invalidity Contentions filed by Airgas Therapeutics LLC, Airgas USA LLC.(Haney, Megan) (Entered: 12/22/2023) (2) |
| Dec 22, 2023 | 150 | NOTICE OF SERVICE of Plaintiffs' Third Set of Requests for the Production of Documents and Things (Nos. 70-73) to Defendants filed by Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited.(Metzler, Sara) (Entered: 12/22/2023) (2) |
| Dec 20, 2023 | 148 | NOTICE OF SERVICE of Plaintiffs' Opening Claim Construction Brief filed by Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited.(Metzler, Sara) (Entered: 12/20/2023) (2) |
| Dec 15, 2023 | 147 | NOTICE OF SERVICE of Airgas Therapeutics and Airgas USA's Supplemental Objections and Responses to Plaintiffs' Interrogatory (No. 6) filed by Airgas Therapeutics LLC, Airgas USA LLC.(Haney, Megan) (Entered: 12/15/2023) (2) |
| Dec 4, 2023 | 146 | NOTICE OF SERVICE of Airgas Therapeutics and Airgas USA's Objections and Responses to Plaintiffs' Second Set of Requests for the Production of Documents and Things (Nos. 65-69) and Airgas Therapeutics and Airgas USA's Objections and Responses to Plaintiff's Third Set of Interrogatories (No. 6) filed by Airgas Therapeutics LLC, Airgas USA LLC.(Haney, Megan) (Entered: 12/04/2023) (2) |
| Dec 1, 2023 | 145 | NOTICE OF SERVICE of Airgas Therapeutics, LLC and Airgas USA, LLC's Third Set of Requests for Production to Plaintiffs (Nos. 115-123) filed by Airgas Therapeutics LLC, Airgas USA LLC.(Haney, Megan) (Entered: 12/01/2023) (2) |
| Nov 20, 2023 | 140 | Joint Claim Construction Chart, Volume 1 of 5, by Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited. (Attachments: # 1 Exhibit A, # 2 Exhibits 1-4)(Farnan, Kelly) Modified on 11/20/2023 (nms). Modified on 11/20/2023 (nms). (Entered: 11/20/2023) (0) |
| Nov 20, 2023 | 141 | Joint Claim Construction Chart, Volume 2 of 5, by Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited. (Attachments: # 1 Exhibits 5-7, part 1)(Farnan, Kelly) Modified on 11/20/2023 (nms). (Entered: 11/20/2023) (0) |
| Nov 20, 2023 | 142 | Joint Claim Construction Chart, Volume 3 of 5, by Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited. (Attachments: # 1 Exhibit 7, part 2 and Exhibit 8, part 1)(Farnan, Kelly) Modified on 11/20/2023 (nms). (Entered: 11/20/2023) (0) |
| Nov 20, 2023 | 143 | Joint Claim Construction Chart, Volume 4 of 5, by Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited. (Attachments: # 1 Exhibit 8, part 2-12)(Farnan, Kelly) Modified on 11/20/2023 (nms). (Entered: 11/20/2023) (0) |
| Nov 20, 2023 | 144 | Joint Claim Construction Chart, Volume 5 of 5, by Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited. (Attachments: # 1 Exhibits 13-16)(Farnan, Kelly) Modified on 11/20/2023 (nms). (Entered: 11/20/2023) (0) |
| Nov 13, 2023 | 138 | NOTICE OF SERVICE of Plaintiffs' Proposed Terms for Claim Construction and Proposed Claim Constructions filed by Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited.(Metzler, Sara) (Entered: 11/13/2023) (2) |
| Nov 13, 2023 | 139 | NOTICE OF SERVICE of Defendants Airgas Therapeutics, LLC and Airgas USA, LLC's Preliminary Identification of Claim Term(s)/Phrase(s) for Construction and Proposed Constructions filed by Airgas Therapeutics LLC, Airgas USA LLC.(Haney, Megan) (Entered: 11/13/2023) (2) |
| Nov 6, 2023 | 137 | ORAL ORDER: The redactions (D.I. 134 ) supported by the Declaration at D.I. 135 are APPROVED. Ordered by Judge Richard G. Andrews on 11/6/2023. (nms) (Entered: 11/06/2023) (0) |
| Nov 3, 2023 | 132 | REDACTED VERSION of 123 Reply Brief by Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited. (Cottrell, Frederick) (Entered: 11/03/2023) (17) |
| Nov 3, 2023 | 133 | REDACTED VERSION of 124 Declaration, by Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited. (Attachments: # 1 Exhibit A-D, # 2 Exhibit E)(Cottrell, Frederick) (Entered: 11/03/2023) (0) |
| Nov 3, 2023 | 134 | REDACTED VERSION of 125 Declaration, by Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited. (Attachments: # 1 Exhibit F)(Cottrell, Frederick) (Entered: 11/03/2023) (0) |
| Nov 3, 2023 | 135 | DECLARATION of Suzanne Hagin re 134 Redacted Version, by Airgas Therapeutics LLC, Airgas USA LLC. (Phillips, John) Modified on 11/3/2023 (nms). (Entered: 11/03/2023) (8) |
| Nov 3, 2023 | 136 | NOTICE OF SERVICE of (1) Second Set of RFPs to Defendants (Nos. 65-69) and (2) Third Set of Interrogatories to Defendants (No. 6) filed by Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited.(Metzler, Sara) (Entered: 11/03/2023) (2) |
| Oct 30, 2023 | 131 | ORAL ORDER: The redaction at D.I. 121 as supported by the Declaration at D.I. 122 is APPROVED. Ordered by Judge Richard G. Andrews on 10/30/2023. (nms) (Entered: 10/30/2023) (0) |
| Oct 27, 2023 | 129 | REQUEST for Oral Argument by Airgas Therapeutics LLC, Airgas USA LLC re 75 MOTION for Preliminary Injunction. (Phillips, John) (Entered: 10/27/2023) (1) |
| Oct 27, 2023 | 130 | STIPULATION and Proposed Order for Extension of Time to submit redacted versions of Reply Brief and Supporting Declaration (D.I. 123-125) to November 3, 2023 - filed by Airgas Therapeutics LLC, Airgas USA LLC. (Haney, Megan) Modified on 10/27/2023 (nms). (Entered: 10/27/2023) (2) |
| Oct 26, 2023 | 128 | REQUEST for Oral Argument by Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited re 75 MOTION for Preliminary Injunction. (Metzler, Sara) (Entered: 10/26/2023) (2) |
| Oct 24, 2023 | 127 | NOTICE OF SERVICE of Plaintiffs' Responses and Objections to Defendants' Second Set of Request for Production of Documents and Things (Nos. 90-114) filed by Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited.(Metzler, Sara) (Entered: 10/24/2023) (2) |
| Oct 23, 2023 | 126 | NOTICE OF SERVICE of Mallinckrodt Pharmaceuticals Ireland Limited and Mallinckrodt Hospital Products IP Unlimited Company's Initial Infringement Contentions filed by Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited.(Metzler, Sara) (Entered: 10/23/2023) (2) |
| Oct 20, 2023 | 121 | REDACTED VERSION of 120 Answering Brief in Opposition, by Airgas Therapeutics LLC, Airgas USA LLC. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D)(Phillips, John) (Entered: 10/20/2023) (0) |
| Oct 20, 2023 | 122 | DECLARATION of Suzanne Hagin in support of 121 Redacted Document, by Airgas Therapeutics LLC, Airgas USA LLC. (Phillips, John) Modified on 10/20/2023 (nms). (Entered: 10/20/2023) (3) |
| Oct 20, 2023 | 123 | [SEALED] REPLY BRIEF re 75 MOTION for Preliminary Injunction filed by Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited. (Cottrell, Frederick) (Entered: 10/20/2023) (0) |
| Oct 20, 2023 | 124 | [SEALED] DECLARATION of Sara M. Metzler, Volume I re 123 Reply Brief, by Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited. (Attachments: # 1 Exhibits A-D, # 2 Exhibit E)(Cottrell, Frederick) Modified on 10/20/2023 (nms). (Entered: 10/20/2023) (0) |
| Oct 20, 2023 | 125 | [SEALED] DECLARATION Sara M. Metzler, Volume II re 123 Reply Brief, by Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited. (Attachments: # 1 Exhibit F-part 1, # 2 Exhibit F-part 2)(Cottrell, Frederick) Modified on 10/20/2023 (nms). (Entered: 10/20/2023) (0) |
| Oct 13, 2023 | 120 | [SEALED] ANSWERING BRIEF in Opposition re 75 MOTION for Preliminary Injunction filed by Airgas Therapeutics LLC, Airgas USA LLC.Reply Brief due date per Local Rules is 10/20/2023. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D)(Phillips, John) (Entered: 10/13/2023) (0) |
| Oct 11, 2023 | 119 | DECLARATION of Lars Taavola in support of Redactions (D.I. 114 , 118 , 117 , and 115 ), by Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited. (Metzler, Sara) Modified on 10/11/2023 (nms). (Entered: 10/11/2023) (3) |
| Oct 10, 2023 | 112 | UNOPPOSED Motion to Seal Reply and Supplemental Declaration in Support of Defendant Air Liquide S.A.'s Motion to Dismiss - filed by Air Liquide S.A.. (Attachments: # 1 Proposed Order)(Farnan, Michael) Modified on 10/10/2023 (nms). (Entered: 10/10/2023) (0) |
| Oct 10, 2023 | 113 | ORDER: The Motion to Seal (D.I. 112 ) is GRANTED. Air Liquide S.A. shall file redacted versions of the sealed filings by no later than October 12, 2023. If the redacted versions are over-redacted the original versions will be summarily unsealed. Signed by Judge Richard G. Andrews on 10/10/2023. (nms) (Entered: 10/10/2023) (1) |
| Oct 10, 2023 | 114 | REDACTED VERSION of 59 Answering Brief in Opposition, by Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited. (Metzler, Sara) (Entered: 10/10/2023) (27) |
| Oct 10, 2023 | 115 | REDACTED VERSION of 60 Declaration, by Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited. (Attachments: # 1 Exhibit 1-14)(Metzler, Sara) (Entered: 10/10/2023) (0) |
| Oct 10, 2023 | 117 | REDACTED VERSION of 108 Reply Brief by Air Liquide S.A.. (Farnan, Michael) (Entered: 10/10/2023) (14) |
| Oct 10, 2023 | 118 | REDACTED VERSION of 109 Declaration by Air Liquide S.A.. (Farnan, Michael) (Entered: 10/10/2023) (3) |
| Oct 2, 2023 | 111 | NOTICE OF SERVICE of Airgas Therapeutics and Airgas USA's Objections and Responses to Plaintiff's First Set of Requests for Admission to Defendants filed by Airgas Therapeutics LLC, Airgas USA LLC.(Haney, Megan) (Entered: 10/02/2023) (2) |
| Sep 28, 2023 | 110 | NOTICE OF SERVICE of Airgas Therapeutics and Airgas USA's Objections and Responses to Plaintiffs' First Set of Requests for the Production of Documents and Things (Nos. 1-64) filed by Airgas Therapeutics LLC, Airgas USA LLC.(Haney, Megan) (Entered: 09/28/2023) (2) |
| Sep 26, 2023 | 108 | SEALED REPLY BRIEF re 37 MOTION to Dismiss, filed by Air Liquide S.A.. (Farnan, Brian) Modified on 10/10/2023 (nms). (Entered: 09/26/2023) (0) |
| Sep 26, 2023 | 109 | SEALED DECLARATION of Jacques Molgo re 108 Reply Brief, by Air Liquide S.A.. (Farnan, Brian) Modified on 9/26/2023 (nms). Modified on 10/10/2023 (nms). (Entered: 09/26/2023) (0) |
| Sep 25, 2023 | 95 | REDACTED VERSION of 63 Letter by Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited. (Attachments: # 1 Exhibit A-C)(Farnan, Kelly) (Entered: 09/25/2023) (0) |
| Sep 25, 2023 | 96 | REDACTED VERSION of 76 Opening Brief in Support, by Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited. (Metzler, Sara) (Entered: 09/25/2023) (29) |
| Sep 25, 2023 | 97 | REDACTED VERSION of 77 Declaration, by Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited. (Attachments: # 1 Exhibit A-O, # 2 Exhibit P)(Metzler, Sara) (Entered: 09/25/2023) (0) |
| Sep 25, 2023 | 98 | REDACTED VERSION of 78 Declaration, by Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited. (Attachments: # 1 Exhibit Q-part 1, # 2 Exhibit Q-part 2, # 3 Exhibit Q-part 3, # 4 Exhibit R, # 5 Exhibit S-part 1)(Metzler, Sara) (Attachment 4 replaced on 9/27/2023) (nms). (Entered: 09/25/2023) (0) |
| Sep 25, 2023 | 99 | REDACTED VERSION of 79 Declaration, by Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited. (Attachments: # 1 Exhibit S-part 2, # 2 Exhibit S-part 3)(Metzler, Sara) (Entered: 09/25/2023) (0) |
| Sep 25, 2023 | 100 | REDACTED VERSION of 80 Declaration, by Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited. (Attachments: # 1 Exhibit S-part 4, # 2 Exhibit S-part 5)(Metzler, Sara) (Entered: 09/25/2023) (0) |
| Sep 25, 2023 | 101 | REDACTED VERSION of 81 Declaration, by Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited. (Attachments: # 1 Exhibit S-part 6, # 2 Exhibit S-part 7)(Metzler, Sara) (Entered: 09/25/2023) (0) |
| Sep 25, 2023 | 102 | REDACTED VERSION of 83 Declaration, by Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited. (Attachments: # 1 Exhibit S-part 8, # 2 Exhibit S-part 9)(Metzler, Sara) (Entered: 09/25/2023) (0) |
| Sep 25, 2023 | 103 | REDACTED VERSION of 84 Declaration, by Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited. (Attachments: # 1 Exhibit S-part 10, # 2 Exhibit S-part 11, # 3 Exhibit S-part 12)(Metzler, Sara) (Entered: 09/25/2023) (0) |
| Sep 25, 2023 | 104 | REDACTED VERSION of 85 Declaration, by Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited. (Attachments: # 1 Exhibit S-part 13, # 2 Exhibit S-part 14, # 3 Exhibit S-part 15)(Metzler, Sara) (Entered: 09/25/2023) (0) |
| Sep 25, 2023 | 105 | REDACTED VERSION of 86 Declaration, by Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited. (Attachments: # 1 Exhibit S-part 16, # 2 Exhibit S-part 17)(Metzler, Sara) (Entered: 09/25/2023) (0) |
| Sep 25, 2023 | 106 | REDACTED VERSION of 87 Declaration, by Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited. (Attachments: # 1 Exhibit T-AA)(Metzler, Sara) (Entered: 09/25/2023) (0) |
| Sep 25, 2023 | 107 | DECLARATION of Lars Taavola in support of redacted filings (D.I. 96 , 98 , 103 , 104 , and 105 , by Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited. (Metzler, Sara) Modified on 9/26/2023 (nms). (Entered: 09/25/2023) (7) |
| Sep 21, 2023 | 93 | ORAL ORDER: Defendants response to the preliminary injunction is due October 13, 2023. Ordered by Judge Richard G. Andrews on 9/21/2023. (nms) (Entered: 09/21/2023) (0) |
| Sep 21, 2023 | 94 | ORAL ORDER: The Stipulation and Proposed Order for Extension of Time (D.I. 92 ) is DENIED. Ordered by Judge Richard G. Andrews on 9/21/2023. (nms) (Entered: 09/21/2023) (0) |
| Sep 20, 2023 | 90 | NOTICE OF SERVICE of (1) Notice of Deposition of S. David Piper; (2) Notice of Deposition of Paul Coiante; (3) Notice of Deposition of Philippe S. Friedlich; and (4) Notice of Deposition of Dana Trexler filed by Airgas Therapeutics LLC, Airgas USA LLC.(Haney, Megan) (Entered: 09/20/2023) (2) |
| Sep 20, 2023 | 91 | Letter to The Honorable Richard G. Andrews, from Frederick L. Cottrell, III, regarding opposition request regarding extension (D.I. 89 ). (Attachments: # 1 Proposed Order, # 2 Proposed Order, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G)(Cottrell, Frederick) Modified on 9/21/2023 (nms). (Entered: 09/20/2023) (0) |
| Sep 20, 2023 | 92 | STIPULATION and Proposed Order for Extension of Time to file redacted versions of D.I. 76, 77, 78, 79, 80, 81, 83, 84, 85, 86, and 87 to 11/3/2023 - filed by Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited. (Metzler, Sara) Modified on 9/21/2023 (nms). (Entered: 09/20/2023) (2) |
| Sep 19, 2023 | 89 | Letter to The Honorable Richard G. Andrews, from John C. Phillips, Jr., regarding request for extension of time to respond to motion for preliminary injunction. (Attachments: # 1 Exhibits A-D, # 2 Proposed Order)(Phillips, John) Modified on 9/20/2023 (nms). (Entered: 09/19/2023) (0) |
| Sep 14, 2023 | 77 | [SEALED] DECLARATION Sara M. Metzler, Volume I re 75 MOTION for Preliminary Injunction, by Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited. (Attachments: # 1 Exhibits A-O, # 2 Exhibit P)(Cottrell, Frederick) Modified on 9/14/2023 (nms). (Entered: 09/14/2023) (0) |
| Sep 14, 2023 | 78 | [SEALED] DECLARATION Sara M. Metzler, Volume II re 76 Motion for Preliminary Injunction, by Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited. (Attachments: # 1 Exhibit Q-part 1, # 2 Exhibit Q-part 2, # 3 Exhibit R, # 4 Exhibit S-part 1)(Cottrell, Frederick) Modified on 9/14/2023 (nms). (Attachment 3 replaced on 9/26/2023) (nms). (Entered: 09/14/2023) (0) |
| Sep 14, 2023 | 79 | [SEALED] DECLARATION Sara M. Metzler, Volume III re 76 Motion for Preliminary Injunction, by Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited. (Attachments: # 1 Exhibit S-part2, # 2 Exhibit S-part 3)(Cottrell, Frederick) Modified on 9/14/2023 (nms). (Entered: 09/14/2023) (0) |
| Sep 14, 2023 | 80 | [SEALED] DECLARATION Sara M. Metzler, Volume IV re 76 Motion for Preliminary Injunction, by Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited. (Attachments: # 1 Exhibit S-part 4, # 2 Exhibit S-part 5)(Cottrell, Frederick) Modified on 9/14/2023 (nms). (Entered: 09/14/2023) (0) |
| Sep 14, 2023 | 81 | [SEALED] DECLARATION Sara M. Metzler, Volume V re 76 Motion for Preliminary Injunction, by Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited. (Attachments: # 1 Exhibit S-part 6, # 2 Exhibit S-part 7)(Cottrell, Frederick) Modified on 9/14/2023 (nms). (Entered: 09/14/2023) (0) |
| Sep 14, 2023 | 82 | PROPOSED Protective Order, by Airgas Therapeutics LLC, Airgas USA LLC. (Haney, Megan) Modified on 9/14/2023 (nms). (Entered: 09/14/2023) (17) |
| Sep 14, 2023 | 83 | [SEALED] DECLARATION Sara M. Metzler, Volume VI re 76 Motion for Preliminary Injunction, by Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited. (Attachments: # 1 Exhibit S-part 8, # 2 Exhibit S-part 9)(Cottrell, Frederick) Modified on 9/14/2023 (nms). (Entered: 09/14/2023) (0) |
| Sep 14, 2023 | 84 | [SEALED] DECLARATION Sara M. Metzler, Volume VII re 76 Motion for Preliminary Injunction, by Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited. (Attachments: # 1 Exhibit S-part 10, # 2 Exhibit S-part 11, # 3 Exhibit S-part 12)(Cottrell, Frederick) Modified on 9/14/2023 (nms). (Entered: 09/14/2023) (0) |
| Sep 14, 2023 | 85 | [SEALED] DECLARATION Sara M. Metzler, Volume VIII re 76 Motion for Preliminary Injunction, by Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited. (Attachments: # 1 Exhibit S-part 13, # 2 Exhibit S-part 14, # 3 Exhibit S-part 15)(Cottrell, Frederick) Modified on 9/14/2023 (nms). (Entered: 09/14/2023) (0) |
| Sep 14, 2023 | 86 | [SEALED] DECLARATION Sara M. Metzler, Volume IX re 76 Motion for Preliminary Injunction, by Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited. (Attachments: # 1 Exhibit S-part 16, # 2 Exhibit S-part 17)(Cottrell, Frederick) Modified on 9/14/2023 (nms). (Entered: 09/14/2023) (0) |
| Sep 14, 2023 | 87 | [SEALED] DECLARATION Sara M. Metzler, Volume X re 76 Motion for Preliminary Injunction, by Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited. (Attachments: # 1 Exhibits T-AA)(Cottrell, Frederick) Modified on 9/14/2023 (nms). (Entered: 09/14/2023) (0) |
| Sep 14, 2023 | 88 | SO ORDERED Granting 82 Protective Order. Signed by Judge Richard G. Andrews on 9/14/2023. (nms) (Entered: 09/14/2023) (17) |
| Sep 13, 2023 | 74 | NOTICE OF SERVICE of Airgas Therapeutics and Airgas USA's Second Set of Requests for Production to Plaintiffs (Nos. 90-114) filed by Airgas Therapeutics LLC, Airgas USA LLC.(Haney, Megan) (Entered: 09/13/2023) (2) |
| Sep 13, 2023 | 75 | MOTION for Preliminary Injunction - filed by Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited. (Attachments: # 1 7.1.1 Statement, # 2 Proposed Order)(Cottrell, Frederick) Modified on 9/14/2023 (nms). (Entered: 09/13/2023) (0) |
| Sep 13, 2023 | 76 | [SEALED] OPENING BRIEF in Support re 75 MOTION for Preliminary Injunction, filed by Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited Answering Brief/Response due date per Local Rules is 9/27/2023. (Cottrell, Frederick) Modified on 9/14/2023 (nms). (Entered: 09/13/2023) (0) |
| Sep 8, 2023 | 69 | ORAL ORDER. Airgas's Motion Regarding Protective Order Disputes (D.I. 57) is GRANTED, and Mallinckrodt's Motion (D.I. 63) is DENIED without prejudice to renew. Although styled as a protective order dispute, Mallinckrodt's request feels more like a request for a disclosure order. Regardless, Airgas sufficiently demonstrated good cause for a provision that would limit use of confidential information to this action rather than giving Mallinckrodt the green light to disclose confidential information regarding Airgas's ANDA outside this litigation. Among other reasons, Airgas pointed out that Mallinckrodt's proposed language would permit disclosure to more than just the FDA (the entity to which Mallinckrodt says it wishes to be able to disclose confidential information), and that the proposed language permits disclosure of matters far broader than what Mallinckrodt identifies in its letter as its chief concern; namely, whether Airgas engaged in an improper attempt to circumvent the 30-month stay. Moreover, according to Mallinckrodt, it has not yet discovered the information that it wishes to disclose to the FDA. If it does, and it can identify the information with specificity, I will hear a dispute promptly on whether Mallinckrodt can satisfy the applicable standard to modify the protective order to permit disclosure. IT IS FURTHER ORDERED that the teleconference scheduled for September 8, 2023 is CANCELLED.. Ordered by Judge Laura D. Hatcher on 9/8/23. (kjk) (Entered: 09/08/2023) (0) |
| Sep 8, 2023 | 70 | STIPULATION and Proposed Order for Extension of Time to submit a redacted version of D.I. 63 to September 22, 2023 - filed by Airgas Therapeutics LLC, Airgas USA LLC. (Haney, Megan) Modified on 9/8/2023 (nms). (Entered: 09/08/2023) (2) |
| Sep 8, 2023 | 71 | REDACTED VERSION of 61 Letter by Airgas Therapeutics LLC, Airgas USA LLC. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2)(Haney, Megan) (Entered: 09/08/2023) (0) |
| Sep 8, 2023 | 72 | REDACTED VERSION of 56 Letter by Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited. (Attachments: # 1 Exhibit 1-7)(Farnan, Kelly) (Entered: 09/08/2023) (0) |
| Sep 8, 2023 | 73 | DECLARATION of Lars Taavola in support of redactions (D.I. 71 , 72 ), by Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited. (Farnan, Kelly) Modified on 9/8/2023 (nms). (Entered: 09/08/2023) (2) |
| Sep 7, 2023 | 68 | Letter to The Honorable Laura D. Hatcher, from Frederick L. Cottrell, III, regarding withdraw of discovery dispute teleconference. (Cottrell, Frederick) Modified on 9/7/2023 (nms). (Entered: 09/07/2023) (1) |
| Sep 5, 2023 | 65 | NOTICE OF SERVICE of (1) Airgas Therapeutics and Airgas USA's Objections and Responses to Plaintiffs' First Set of Expedited Requests for Inspection and Testing to Defendants; (2) Airgas Therapeutics and Airgas USA's Objections and Responses to Plaintiffs' Second Set of Interrogatories (Nos. 3-5); and (3) Airgas Therapeutics and Airgas USA's Objections and Responses to Plaintiffs' First Set of Expedited Requests for the Production of Documents and Things (Nos. 1-7) filed by Airgas Therapeutics LLC, Airgas USA LLC.(Haney, Megan) (Entered: 09/05/2023) (2) |
| Sep 5, 2023 | 66 | NOTICE OF SERVICE of (1) Plaintiffs Responses and Objections to Airgas Therapeutics LLC and Airgas USA, LLCs Frist Set of Requests for Production of Documents and Things (Nos. 1-89 and (2) Plaintiffs Responses and Objections to Defendant Airgass First Set of Expedited Request for Production of Documents and Things (Nos. 1-9) filed by Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited.(Metzler, Sara) (Entered: 09/05/2023) (2) |
| Sep 5, 2023 | 67 | STIPULATION and Proposed Order for Extension of Time to submit redacted version D.I. 59 and D.I. 60 to October 10, 2023 - filed by Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited. (Metzler, Sara) Modified on 9/6/2023 (nms). (Entered: 09/05/2023) (2) |
| Sep 1, 2023 | 61 | [SEALED] Letter to The Honorable Laura D. Hatcher, from Megan C. Haney, regarding Defendants' expert Steve Han. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2)(Haney, Megan) Modified on 9/1/2023 (nms). (Entered: 09/01/2023) (0) |
| Sep 1, 2023 | 62 | STIPULATION and Proposed Order for Extension of Time to submit a redacted version D.I. 56 to September 8, 2023 - filed by Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited. (Metzler, Sara) Modified on 9/1/2023 (nms). (Entered: 09/01/2023) (2) |
| Sep 1, 2023 | 63 | [SEALED] Letter to The Honorable Laura D. Hatcher, from Kelly E. Farnan, regarding protective order dispute. (Attachments: # 1 Exhibits A-C)(Farnan, Kelly) Modified on 9/1/2023 (nms). (Entered: 09/01/2023) (0) |
| Sep 1, 2023 | 64 | NOTICE OF SERVICE of Plaintiffs' First Set of Requests for Admission to Defendants (Nos. 1-10) to Defendants filed by Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited.(Metzler, Sara) (Entered: 09/01/2023) (2) |
| Aug 29, 2023 | 59 | [SEALED] ANSWERING BRIEF in Opposition re 37 MOTION to Dismiss filed by Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited.Reply Brief due date per Local Rules is 9/5/2023. (Metzler, Sara) (Entered: 08/29/2023) (0) |
| Aug 29, 2023 | 60 | [SEALED] DECLARATION of Sara M. Metzle re 59 Answering Brief in Opposition, by Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited. (Attachments: # 1 Exhibits 1-8, # 2 Exhibits 9-14)(Metzler, Sara) Modified on 8/29/2023 (nms). (Entered: 08/29/2023) (0) |
| Aug 28, 2023 | 58 | NOTICE OF SERVICE of Plaintiffs First Set of Requests for the Production of Documents and Things (Nos. 1-64) to Defendants filed by Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited.(Farnan, Kelly) (Entered: 08/28/2023) (2) |
| Aug 25, 2023 | 56 | [SEALED] Letter to The Honorable Laura D. Hatcher, from Kelly E. Farnan, regarding discovery dispute. (Attachments: # 1 Exhibits 1-7)(Farnan, Kelly) Modified on 8/26/2023 (nms). (Entered: 08/25/2023) (0) |
| Aug 25, 2023 | 57 | Letter to the Honorable Laura D. Hatcher, from Megan C. Haney, regarding protective order dispute. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E)(Haney, Megan) Modified on 8/26/2023 (nms). (Entered: 08/25/2023) (0) |
| Aug 22, 2023 | 55 | ORAL ORDER The Court has reviewed the Motion for Teleconference to Resolve Discovery Dispute (D.I. 53). A discovery dispute teleconference is scheduled for September 8, 2023 at 1:00 PM Eastern Time before Judge Laura D. Hatcher. By no later than August 25, 2023, each party seeking relief shall file with the Court a letter, not to exceed three pages, in no less than 12-point font, outlining the issues in dispute and its position on those issues. By no later than September 1, 2023, any party opposing an application for relief may file a letter, not to exceed 3 pages, in no less than 12-point font, outlining that party's reasons for its opposition. Counsel is reminded to promptly provide courtesy copies. Counsel shall send dial-in information directly to the Court, no later than 24 hours prior to the hearing, using the following e-mail address: keith_kincaid@ded.uscourts.gov. The Court may choose to resolve the dispute prior to the telephone conference and will in that event cancel the conference. Ordered by Judge Laura D. Hatcher on 8/22/23. (kjk) (Entered: 08/22/2023) (0) |
| Aug 21, 2023 | 54 | NOTICE OF SERVICE of Airgas Therapeutics and Airgas USA's Objections and Responses to Plaintiff's First Set of Interrogatories (Nos. 1-2) filed by Airgas Therapeutics LLC, Airgas USA LLC.(Haney, Megan) (Entered: 08/21/2023) (2) |
| Aug 18, 2023 | 53 | Letter to the Honorable Laura D. Hatcher, from Frederick L. Cottrell, III, regarding discovery dispute. (Cottrell, Frederick) Modified on 8/21/2023 (nms). (Entered: 08/18/2023) (1) |
| Aug 14, 2023 | 51 | NOTICE OF SERVICE of (1) Rule 26(a)(1) Initial Disclosures and (2) Initial Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery filed by Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited.(Metzler, Sara) (Entered: 08/14/2023) (2) |
| Aug 14, 2023 | 52 | NOTICE OF SERVICE of Defendants Airgas Therapeutics, LLC and Airgas USA, LLC's Rule 26(a)(1) Initial Disclosures and Defendants Airgas Therapeutics, LLC and Airgas USA, LLC's Initial Paragraph 3 Disclosures filed by Airgas Therapeutics LLC, Airgas USA LLC.(Phillips, John) (Entered: 08/14/2023) (2) |
| Aug 7, 2023 | 49 | ORAL ORDER: The motion to seal (D.I. 36 ) is DENIED. The only basis for the request appears to keep secret exactly which corporate relative of the Air Liquide family filed the ANDA. How the release of that entitys name works any harm to anyone is unexplained. Ordered by Judge Richard G. Andrews on 8/7/2023. (nms) (Entered: 08/07/2023) (0) |
| Aug 7, 2023 | 50 | SCHEDULING ORDER: Case referred to the Magistrate Judge Laura D. Hatcher for discovery. Joinder of Parties due by 2/1/2024. Amended Pleadings due by 2/1/2024. Discovery due by 6/3/2024. Joint Claim Construction Brief due by 3/6/2024. A Markman Hearing is set for 3/19/2024, at 10:00 AM in Courtroom 6A. A Pretrial Conference is set for 2/21/2025, at 9:00 AM in Courtroom 6A. A 3-day Bench Trial is set to start on 3/10/2025, at 8:30 AM in Courtroom 6A (see Order for further details). Signed by Judge Richard G. Andrews on 8/7/2023. (nms) Modified on 8/7/2023 (kjk). (Entered: 08/07/2023) (13) |
| Aug 4, 2023 | 42 | NOTICE of Change of Address by Kelly E. Farnan (Farnan, Kelly) (Entered: 08/04/2023) (2) |
| Aug 4, 2023 | 43 | REDACTED VERSION of 33 Letter by Airgas Therapeutics LLC, Airgas USA LLC. (Phillips, John) (Entered: 08/04/2023) (1) |
| Aug 4, 2023 | 44 | REDACTED VERSION of 38 Opening Brief in Support by Air Liquide S.A.. (Attachments: # 1 Certificate of Service)(Farnan, Brian) (Entered: 08/04/2023) (0) |
| Aug 4, 2023 | 45 | REDACTED VERSION of 39 Declaration by Air Liquide S.A.. (Attachments: # 1 Exhibits A-B, # 2 Certificate of Service)(Farnan, Brian) (Entered: 08/04/2023) (0) |
| Aug 4, 2023 | 46 | REDACTED VERSION of 34 Letter by Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited. (Cottrell, Frederick) (Entered: 08/04/2023) (2) |
| Aug 4, 2023 | 47 | PROPOSED Scheduling Order, by Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited. (Metzler, Sara) Modified on 8/4/2023 (nms). (Entered: 08/04/2023) (13) |
| Aug 4, 2023 | 48 | NOTICE OF SERVICE of (1) Plaintiffs' First Set of Expedited Requests for the Production of Documents and Things (Nos. 1-7) to Defendants; (2) Plaintiffs' First Expedited Requests For Inspection and Testing to Defendants and (3) Plaintiffs' Second Set of Interrogatories to Defendants (Nos. 3-5) filed by Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited.(Metzler, Sara) (Entered: 08/04/2023) (2) |
| Aug 3, 2023 | 41 | NOTICE OF SERVICE of Airgas Therapeutics and Airgas USA's First Set of Expedited Requests for Production to Plaintiffs (Nos. 1-9) and Airgas Therapeutics and Airgas USA's First Set of Requests for Production to Plaintiffs (Nos. 1-89) filed by Airgas Therapeutics LLC, Airgas USA LLC.(Haney, Megan) (Entered: 08/03/2023) (2) |
| Jul 31, 2023 | 36 | UNOPPOSED Motion to Seal Memorandum and Declaration in Support of Motion to Dismiss - filed by Air Liquide S.A.. (Attachments: # 1 Proposed Order, # 2 7.1.1 Certification)(Farnan, Brian) Modified on 7/31/2023 (nms). (Entered: 07/31/2023) (0) |
| Jul 31, 2023 | 37 | MOTION to Dismiss - filed by Air Liquide S.A.. (Farnan, Brian) Modified on 7/31/2023 (nms). (Entered: 07/31/2023) (2) |
| Jul 31, 2023 | 38 | OPENING BRIEF in Support re 37 MOTION to Dismiss, filed by Air Liquide S.A..Answering Brief/Response due date per Local Rules is 8/14/2023. (Attachments: # 1 Certificate of Service)(Farnan, Brian) Modified on 7/31/2023 (nms). Modified on 8/7/2023 (nms). (Entered: 07/31/2023) (0) |
| Jul 31, 2023 | 39 | DECLARATION of Jacques Molgo re 38 Opening Brief in Support, by Air Liquide S.A.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Certificate of Service)(Farnan, Brian) Modified on 7/31/2023 (nms). Modified on 8/7/2023 (nms). (Entered: 07/31/2023) (0) |
| Jul 31, 2023 | 40 | MOTION for Pro Hac Vice Appearance of Attorney Sasha S. Rao, John D. Higgins, Trevor M. ONeill, and Richa B. Patel - filed by Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited. (Metzler, Sara) (Entered: 07/31/2023) (6) |
| Jul 28, 2023 | 32 | ORAL ORDER: The Rule 16(b) Scheduling Conference set for 7/31/2023, will now be held at 11:30 AM. Ordered by Judge Richard G. Andrews on 7/28/2023. (lah) (Entered: 07/28/2023) (0) |
| Jul 28, 2023 | 33 | [SEALED] Letter to The Honorable Richard G. Andrews, from John C. Phillips, Jr., regarding update. (Phillips, John) Modified on 7/30/2023 (nms). (Entered: 07/28/2023) (0) |
| Jul 28, 2023 | 34 | [SEALED] Emergency Letter to The Honorable Richard G. Andrews, from Frederick L. Cottrell, III, regarding response to Defendant's letter -(D.I. 33 ). (Cottrell, Frederick) Modified on 7/30/2023 (nms). (Entered: 07/28/2023) (0) |
| Jul 28, 2023 | 35 | Letter to The Honorable Richard G. Andrews, from Kelly E. Farnan, regarding protective order dispute (D.I. 31 ). (Attachments: # 1 Exhibits 1-3)(Farnan, Kelly) Modified on 7/30/2023 (nms). (Entered: 07/28/2023) (0) |
| Jul 27, 2023 | 30 | Joint Letter to The Honorable Richard G. Andrews, from Kelly E. Farnan, regarding Proposed Scheduling Order. (Attachments: # 1 Proposed Order)(Farnan, Kelly) Modified on 7/27/2023 (nms). (Entered: 07/27/2023) (0) |
| Jul 27, 2023 | 31 | Letter to the Honorable Richard G. Andrews, from John C. Phillips, Jr., regarding protective order dispute. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Phillips, John) Modified on 8/1/2023 (nms). (Entered: 07/27/2023) (0) |
| Jul 7, 2023 | 29 | NOTICE OF SERVICE of First Set of Interrogatories to Defendants (Nos. 1-2) filed by Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited.(Metzler, Sara) (Entered: 07/07/2023) (2) |
| Jun 27, 2023 | 28 | Letter to to the Honorable Richard G. Andrews, from Kelly E. Farnan, regarding regarding Airgas letter dated June 26, 2023 (D.I. 27). (Farnan, Kelly) Modified on 6/28/2023 (nms). (Entered: 06/27/2023) (1) |
| Jun 26, 2023 | 26 | ORAL ORDER: A response from Airgas regarding Plaintiffs' June 23, 2023, letter (D.I 25 ) is due to be filed no later than June 29, 2023. Ordered by Judge Richard G. Andrews on 6/26/2023. (nms) (Entered: 06/26/2023) (0) |
| Jun 26, 2023 | 27 | Letter to The Honorable Richard G. Andrews, from John C. Phillips, Jr., regarding sesponse to Plaintiff's letter dated June 23, 2023 (D.I. 25). (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3)(Phillips, John) Modified on 6/26/2023 (nms). (Entered: 06/26/2023) (Main Document) (3) |
| Jun 26, 2023 | 27 | Letter to The Honorable Richard G. Andrews, from John C. Phillips, Jr., regarding sesponse to Plaintiff's letter dated June 23, 2023 (D.I. 25). (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3)(Phillips, John) Modified on 6/26/2023 (nms). (Entered: 06/26/2023) (Exhibit 1) (3) |
| Jun 26, 2023 | 27 | Letter to The Honorable Richard G. Andrews, from John C. Phillips, Jr., regarding sesponse to Plaintiff's letter dated June 23, 2023 (D.I. 25). (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3)(Phillips, John) Modified on 6/26/2023 (nms). (Entered: 06/26/2023) (Exhibit 2) (4) |
| Jun 26, 2023 | 27 | Letter to The Honorable Richard G. Andrews, from John C. Phillips, Jr., regarding sesponse to Plaintiff's letter dated June 23, 2023 (D.I. 25). (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3)(Phillips, John) Modified on 6/26/2023 (nms). (Entered: 06/26/2023) (Exhibit 3) (3) |
| Jun 23, 2023 | 25 | Letter to The Honorable Richard G. Andrews, from Kelly E. Faran, regarding timing of ANDA production and launch notice. (Farnan, Kelly) Modified on 6/23/2023 (nms). (Entered: 06/23/2023) (2) |
| Jun 22, 2023 | 24 | Order Setting Rule 16(b) Conference: A Scheduling Conference is set for 7/31/2023, at 2:00 PM in Courtroom 6A (see Order for further details). Signed by Judge Richard G. Andrews on 6/22/2023. (nms) (Entered: 06/22/2023) (1) |
| Jun 21, 2023 | N/A | Pro Hac Vice Attorney James S. Fullmer and Daniel Schimmel for Air Liquide S.A. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) (Entered: 06/21/2023) (0) |
| Jun 20, 2023 | 22 | MOTION for Pro Hac Vice Appearance of Attorney Daniel Schimmel and James S. Fullmer - filed by Air Liquide S.A.. (Farnan, Brian) (Entered: 06/20/2023) (3) |
| Jun 20, 2023 | N/A | SO ORDERED, re 22 MOTION for Pro Hac Vice Appearance of Attorney Daniel Schimmel and James S. Fullmer, filed by Air Liquide S.A.. Signed by Judge Richard G. Andrews on 6/20/2023. (nms) (Entered: 06/20/2023) (0) |
| Jun 20, 2023 | 23 | Letter to The Honorable Richard G. Andrews, from Kelly E. Farnan, regarding response to Airgas June 16 letter (D.I. 21 ). (Attachments: # 1 Exhibits 1-2)(Farnan, Kelly) Modified on 6/21/2023 (nms). (Entered: 06/20/2023) (Main Document) (2) |
| Jun 20, 2023 | 23 | Letter to The Honorable Richard G. Andrews, from Kelly E. Farnan, regarding response to Airgas June 16 letter (D.I. 21 ). (Attachments: # 1 Exhibits 1-2)(Farnan, Kelly) Modified on 6/21/2023 (nms). (Entered: 06/20/2023) (Exhibit 1-2) (11) |
| Jun 16, 2023 | 20 | Letter to The Honorable Richard G. Andrews, from Brian E. Farnan, responding to Plaintiffs' June 14, 2023, letter. (Farnan, Brian) Modified on 6/16/2023 (nms). (Entered: 06/16/2023) (2) |
| Jun 16, 2023 | 21 | Letter to The Honorable Richard G. Andrews, from John C. Phillips, Jr., regarding response to letter filed by Plaintiffs on June 14, 2023 (D.I. 19). (Phillips, John) Modified on 6/16/2023 (nms). (Entered: 06/16/2023) (2) |
| Jun 14, 2023 | 19 | Letter to The Honorable Richard G. Andrews, from Frederick L. Cottrell, III, regarding request to schedule a Rule 16 conference. (Cottrell, Frederick) Modified on 6/14/2023 (nms). (Entered: 06/14/2023) (2) |
| May 30, 2023 | 18 | SO ORDERED Granting 17 Joint Stipulation Regarding Service of Complaint on Air Liquide S.A. and Scheduling Response Thereto (*Reset Answer Deadlines: Air Liquide S.A. answer due 7/31/2023). Signed by Judge Richard G. Andrews on 5/30/2023. (nms) (Entered: 05/30/2023) (3) |
| May 26, 2023 | 17 | Joint Stipulation Regarding Service of Complaint on Air Liquide S.A. and Scheduling Response Thereto, by Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited. (Farnan, Kelly) Modified on 5/30/2023 (nms). (Entered: 05/26/2023) (3) |
| Apr 6, 2023 | 16 | Summons Issued as to Air Liquide S.A. on 4/6/2023. (smg) (Entered: 04/10/2023) (2) |
| Apr 5, 2023 | 15 | Letter to Honorable Richard G. Andrews, from Kelly E. Farnan, regarding service on Defendant Air Liquide S.A.. (Farnan, Kelly) Modified on 4/6/2023 (nms). (Entered: 04/05/2023) (2) |
| Apr 3, 2023 | 14 | ORAL ORDER: Whereas more than 90 days have elapsed since the Complaint was filed, and summons have not been requested or issued for Defendant Air Liquide S.A.. Plaintiff is now requested to file a status letter within 3 days of this Order. Ordered by Judge Richard G. Andrews on 4/3/2023. (nms) (Entered: 04/03/2023) (0) |
| Mar 31, 2023 | N/A | Pro Hac Vice Attorney Grace Tuyiringire for Mallinckrodt Hospital Products IP Unlimited Company,and Mallinckrodt Pharmaceuticals Ireland Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (apk) (Entered: 03/31/2023) (0) |
| Mar 24, 2023 | 12 | ANSWER to 11 Answer to Complaint, Counterclaim by Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited.(Farnan, Kelly) (Entered: 03/24/2023) (30) |
| Mar 24, 2023 | 13 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: November 18, 2022. Date of Expiration of Patent: See Appendix.Thirty Month Stay Deadline: 5/18/2025. (Farnan, Kelly) (Entered: 03/24/2023) (2) |
| Mar 23, 2023 | N/A | Pro Hac Vice Attorney Marsha Rose Gillentine,Christina E. Dashe,Richard D. Coller for Mallinckrodt Hospital Products IP Unlimited Company and Mallinckrodt Pharmaceuticals Ireland Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (apk) (Entered: 03/23/2023) (0) |
| Mar 22, 2023 | N/A | Pro Hac Vice Attorney Adam C. LaRock for Mallinckrodt Hospital Products IP Unlimited Company and Mallinckrodt Pharmaceuticals Ireland Limited. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mkr) (Entered: 03/22/2023) (0) |
| Mar 22, 2023 | N/A | Pro Hac Vice Attorney Alexander V. Alfano, Adam C. LaRock, and Dennies Varughese for Mallinckrodt Hospital Products IP Unlimited Company and Mallinckrodt Pharmaceuticals Ireland Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) (Entered: 03/22/2023) (0) |
| Mar 3, 2023 | 11 | ANSWER to 1 Complaint, Affirmative Defenses and COUNTERCLAIMS against All Plaintiffs, by Airgas USA LLC, Airgas Therapeutics LLC.(Phillips, John) Modified on 3/3/2023 (nms). (Entered: 03/03/2023) (30) |
| Mar 1, 2023 | 10 | MOTION for Pro Hac Vice Appearance of Attorney Dennies Varughese, Pharm.D., Adam C. LaRock, Marsha Rose Gillentine, Ph.D., Alex Alfano, Christina E. Dashe, Grace Tuyiringire, Robert E. Niemeier, Ryan E. Conkin, and Richard D. Coller III - filed by Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited. (Metzler, Sara) (Entered: 03/01/2023) (11) |
| Mar 1, 2023 | N/A | SO ORDERED, re 10 MOTION for Pro Hac Vice Appearance of Attorney Dennies Varughese, Pharm.D., Adam C. LaRock, Marsha Rose Gillentine, Ph.D., Alex Alfano, Christina E. Dashe, Grace Tuyiringire, Robert E. Niemeier, Ryan E. Conkin, and Richard D. Coller III, filed by Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited. Signed by Judge Richard G. Andrews on 3/1/2023. (nms) (Entered: 03/01/2023) (0) |
| Feb 3, 2023 | N/A | Pro Hac Vice Attorney Roger H. Lee, Mythili Markowski, Andrew R. Cheslock, S. Lloyd Smith, Grant S. Shackelford, Matthew L. Fedowitz, and Erin A. Napoleon for Airgas Therapeutics LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) (Entered: 02/03/2023) (0) |
| Feb 2, 2023 | N/A | DEFICIENCY NOTICE issued by the Court to Defendants Airgas Therapeutics LLC and Airgas USA LLC: Pursuant to Fed. R. Civ. P. 7.1 (b)(1), A party must: (1) file the disclosure statement with its first appearance, pleading, petition, motion, response, or other request addressed to the court. Counsel is requested to supplement the docket with an appropriate Rule 7.1 Disclosure Statement. (nms) (Entered: 02/02/2023) (0) |
| Feb 2, 2023 | 8 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Airgas, Inc. for Airgas Therapeutics LLC, Airgas USA LLC filed by Airgas Therapeutics LLC, Airgas USA LLC. (Phillips, John) (Entered: 02/02/2023) (2) |
| Feb 2, 2023 | 9 | MOTION for Pro Hac Vice Appearance of Attorney Matthew Fedowitz, Roger H. Lee, S. Lloyd Smith, Andrew R. Cheslock, Grant Shackelford, Mythili Markowski and Erin A. Napoleon - filed by Airgas Therapeutics LLC, Airgas USA LLC. (Attachments: # 1 Certification of Matthew Fedowitz, # 2 Certification of Roger H. Lee, # 3 Certification of S. Lloyd Smith, # 4 Certification of Andrew R. Cheslock, # 5 Certification of Grant Shackelford, # 6 Certification of Mythili Markowski, # 7 Certification of Erin A. Napoleon)(Phillips, John) (Entered: 02/02/2023) (Main Document) (3) |
| Feb 2, 2023 | N/A | SO ORDERED, re 9 MOTION for Pro Hac Vice Appearance of Attorney Matthew Fedowitz, Roger H. Lee, S. Lloyd Smith, Andrew R. Cheslock, Grant Shackelford, Mythili Markowski and Erin A. Napoleon, filed by Airgas USA LLC, Airgas Therapeutics LLC. Signed by Judge Richard G. Andrews on 2/2/2023. (nms) (Entered: 02/02/2023) (0) |
| Feb 2, 2023 | 9 | MOTION for Pro Hac Vice Appearance of Attorney Matthew Fedowitz, Roger H. Lee, S. Lloyd Smith, Andrew R. Cheslock, Grant Shackelford, Mythili Markowski and Erin A. Napoleon - filed by Airgas Therapeutics LLC, Airgas USA LLC. (Attachments: # 1 Certification of Matthew Fedowitz, # 2 Certification of Roger H. Lee, # 3 Certification of S. Lloyd Smith, # 4 Certification of Andrew R. Cheslock, # 5 Certification of Grant Shackelford, # 6 Certification of Mythili Markowski, # 7 Certification of Erin A. Napoleon)(Phillips, John) (Entered: 02/02/2023) (Certification of Matthew Fedowitz) (2) |
| Feb 2, 2023 | 9 | MOTION for Pro Hac Vice Appearance of Attorney Matthew Fedowitz, Roger H. Lee, S. Lloyd Smith, Andrew R. Cheslock, Grant Shackelford, Mythili Markowski and Erin A. Napoleon - filed by Airgas Therapeutics LLC, Airgas USA LLC. (Attachments: # 1 Certification of Matthew Fedowitz, # 2 Certification of Roger H. Lee, # 3 Certification of S. Lloyd Smith, # 4 Certification of Andrew R. Cheslock, # 5 Certification of Grant Shackelford, # 6 Certification of Mythili Markowski, # 7 Certification of Erin A. Napoleon)(Phillips, John) (Entered: 02/02/2023) (Certification of Roger H. Lee) (2) |
| Feb 2, 2023 | 9 | MOTION for Pro Hac Vice Appearance of Attorney Matthew Fedowitz, Roger H. Lee, S. Lloyd Smith, Andrew R. Cheslock, Grant Shackelford, Mythili Markowski and Erin A. Napoleon - filed by Airgas Therapeutics LLC, Airgas USA LLC. (Attachments: # 1 Certification of Matthew Fedowitz, # 2 Certification of Roger H. Lee, # 3 Certification of S. Lloyd Smith, # 4 Certification of Andrew R. Cheslock, # 5 Certification of Grant Shackelford, # 6 Certification of Mythili Markowski, # 7 Certification of Erin A. Napoleon)(Phillips, John) (Entered: 02/02/2023) (Certification of S. Lloyd Smith) (2) |
| Feb 2, 2023 | 9 | MOTION for Pro Hac Vice Appearance of Attorney Matthew Fedowitz, Roger H. Lee, S. Lloyd Smith, Andrew R. Cheslock, Grant Shackelford, Mythili Markowski and Erin A. Napoleon - filed by Airgas Therapeutics LLC, Airgas USA LLC. (Attachments: # 1 Certification of Matthew Fedowitz, # 2 Certification of Roger H. Lee, # 3 Certification of S. Lloyd Smith, # 4 Certification of Andrew R. Cheslock, # 5 Certification of Grant Shackelford, # 6 Certification of Mythili Markowski, # 7 Certification of Erin A. Napoleon)(Phillips, John) (Entered: 02/02/2023) (Certification of Andrew R. Cheslock) (2) |
| Feb 2, 2023 | 9 | MOTION for Pro Hac Vice Appearance of Attorney Matthew Fedowitz, Roger H. Lee, S. Lloyd Smith, Andrew R. Cheslock, Grant Shackelford, Mythili Markowski and Erin A. Napoleon - filed by Airgas Therapeutics LLC, Airgas USA LLC. (Attachments: # 1 Certification of Matthew Fedowitz, # 2 Certification of Roger H. Lee, # 3 Certification of S. Lloyd Smith, # 4 Certification of Andrew R. Cheslock, # 5 Certification of Grant Shackelford, # 6 Certification of Mythili Markowski, # 7 Certification of Erin A. Napoleon)(Phillips, John) (Entered: 02/02/2023) (Certification of Grant Shackelford) (2) |
| Feb 2, 2023 | 9 | MOTION for Pro Hac Vice Appearance of Attorney Matthew Fedowitz, Roger H. Lee, S. Lloyd Smith, Andrew R. Cheslock, Grant Shackelford, Mythili Markowski and Erin A. Napoleon - filed by Airgas Therapeutics LLC, Airgas USA LLC. (Attachments: # 1 Certification of Matthew Fedowitz, # 2 Certification of Roger H. Lee, # 3 Certification of S. Lloyd Smith, # 4 Certification of Andrew R. Cheslock, # 5 Certification of Grant Shackelford, # 6 Certification of Mythili Markowski, # 7 Certification of Erin A. Napoleon)(Phillips, John) (Entered: 02/02/2023) (Certification of Mythili Markowski) (2) |
| Feb 2, 2023 | 9 | MOTION for Pro Hac Vice Appearance of Attorney Matthew Fedowitz, Roger H. Lee, S. Lloyd Smith, Andrew R. Cheslock, Grant Shackelford, Mythili Markowski and Erin A. Napoleon - filed by Airgas Therapeutics LLC, Airgas USA LLC. (Attachments: # 1 Certification of Matthew Fedowitz, # 2 Certification of Roger H. Lee, # 3 Certification of S. Lloyd Smith, # 4 Certification of Andrew R. Cheslock, # 5 Certification of Grant Shackelford, # 6 Certification of Mythili Markowski, # 7 Certification of Erin A. Napoleon)(Phillips, John) (Entered: 02/02/2023) (Certification of Erin A. Napoleon) (2) |
| Feb 1, 2023 | 7 | STIPULATION TO EXTEND TIME for Airgas to answer Complaint to March 3, 2023 - filed by Airgas Therapeutics LLC, Airgas USA LLC. (Haney, Megan) (Entered: 02/01/2023) (2) |
| Feb 1, 2023 | N/A | SO ORDERED, re 7 STIPULATION of Extension of Time To Answer the Complaint (*Reset Answer Deadlines: Airgas Therapeutics LLC answer due 3/3/2023; Airgas USA LLC answer due 3/3/2023). Signed by Judge Richard G. Andrews on 2/1/2023. (nms) (Entered: 02/01/2023) (0) |
| Jan 11, 2023 | 5 | SUMMONS Returned Executed by Mallinckrodt Pharmaceuticals Ireland Limited, Mallinckrodt Hospital Products IP Unlimited Company.Airgas Therapeutics LLC served on 1/11/2023, answer due 2/1/2023. (Cottrell, Frederick) (Entered: 01/11/2023) (2) |
| Jan 11, 2023 | 6 | SUMMONS Returned Executed by Mallinckrodt Pharmaceuticals Ireland Limited, Mallinckrodt Hospital Products IP Unlimited Company.Airgas USA LLC served on 1/11/2023, answer due 2/1/2023. (Cottrell, Frederick) (Entered: 01/11/2023) (2) |
| Jan 10, 2023 | N/A | DEFICIENCY NOTICE issued by the Court to Plaintiff: Pursuant to F.R.C.P. 7.1(b)(1), "A party must: (1) file the disclosure statement with its first appearance, pleading, petition, motion, response, or other request addressed to the court. Counsel is requested to supplement the docket with an appropriate Rule 7.1 Disclosure Statement. (nmg) (Entered: 01/10/2023) (0) |
| Jan 10, 2023 | 4 | Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Mallinckrodt plc for Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited filed by Mallinckrodt Hospital Products IP Unlimited Company, Mallinckrodt Pharmaceuticals Ireland Limited. (Cottrell, Frederick) (Entered: 01/10/2023) (1) |
| Jan 4, 2023 | N/A | Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) (Entered: 01/04/2023) (0) |
| Dec 30, 2022 | 1 | COMPLAINT for PATENT INFRINGEMENT filed against Air Liquide S.A., Airgas Therapeutics LLC, and Airgas USA LLC (Filing fee $ 402, receipt number ADEDC-4034434.) - filed by Mallinckrodt Pharmaceuticals Ireland Limited and Mallinckrodt Hospital Products IP Unlimited Company. (Attachments: # 1 Exhibit 1-15, # 2 Civil Cover Sheet)(mkr) (Entered: 01/03/2023) (Main Document) (30) |
| Dec 30, 2022 | 2 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mkr) (Entered: 01/03/2023) (3) |
| Dec 30, 2022 | 3 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,770,570; 9,279,794; 9,295,802; 9,408,993; 8,795,741; 8,291,904; 8,573,209; 8,573,210; 8,776,794; 8,776,795. (mkr) (Entered: 01/03/2023) (3) |
| Dec 30, 2022 | N/A | No Summons Issued. (mkr) (Entered: 01/03/2023) (0) |
| Dec 30, 2022 | 1 | COMPLAINT for PATENT INFRINGEMENT filed against Air Liquide S.A., Airgas Therapeutics LLC, and Airgas USA LLC (Filing fee $ 402, receipt number ADEDC-4034434.) - filed by Mallinckrodt Pharmaceuticals Ireland Limited and Mallinckrodt Hospital Products IP Unlimited Company. (Attachments: # 1 Exhibit 1-15, # 2 Civil Cover Sheet)(mkr) (Entered: 01/03/2023) (Exhibit 1-15) (30) |
| Dec 30, 2022 | 1 | COMPLAINT for PATENT INFRINGEMENT filed against Air Liquide S.A., Airgas Therapeutics LLC, and Airgas USA LLC (Filing fee $ 402, receipt number ADEDC-4034434.) - filed by Mallinckrodt Pharmaceuticals Ireland Limited and Mallinckrodt Hospital Products IP Unlimited Company. (Attachments: # 1 Exhibit 1-15, # 2 Civil Cover Sheet)(mkr) (Entered: 01/03/2023) (Civil Cover Sheet) (2) |
